Three other LLMs (Deepseek-R1:83%, Claude-3.5S:82%, Llama-3.1:81%) and the clinical model performed comparably to physicians (78-84%, p>0.05), collectively surpassing tumor markers (CA19–9 accuracy:66%, CEA:71%). Here, CEACAM5 is linked to neoplasm.